Trademark: 79133404
Word
NICOX
Status
Registered
Status Code
708
Status Date
Wednesday, February 3, 2021
Serial Number
79133404
Registration Number
4582232
Registration Date
Tuesday, August 12, 2014
Mark Type
3000
Filing Date
Thursday, April 18, 2013
Published for Opposition
Tuesday, May 27, 2014

Trademark Owner History
NICOX SA - Original Registrant

Classifications
5 [ Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of ocular and ophthalmological diseases; respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Dietetic foods adapted for medical use, namely, meal replacement bars, meal replacement drink mixes, minerals, vitamins ]
35 [ Online retail and wholesale store services featuring pharmaceutical products, dietary supplements, dietetic substances adapted for medical use, medical apparatus and instruments, and diagnostic apparatus for medical purposes ]
44 [ Medical evaluation services in the fields of ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, and burns, for purposes of guiding treatment ]
10 [ Medical apparatus and instruments for use in the treatment of ocular and ophthalmological disease, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous systems disease, musculoskeletal systems disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Diagnostic apparatus for medical purposes for detecting ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns ]
42 Scientific and medical research; analysis and scientific research services in the pharmaceutical field; research services in the pharmaceutical field relative to traceability and quality control of making pharmaceutical products
The mark consists of the stylized wording "NICOX" and a circular design.
Color is not claimed as a feature of the mark.

Trademark Events
Aug 12, 2023
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
May 12, 2023
International Registration Renewed
Nov 28, 2021
Partial Invalidation Processed By The Ib
Oct 29, 2021
Partial Invalidation Of Reg Ext Protection Sent To Ib
Oct 29, 2021
Invalidation Processed
Oct 3, 2021
Partial Invalidation Of Reg Ext Protection Created
Feb 3, 2021
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Feb 3, 2021
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Feb 1, 2021
Case Assigned To Post Registration Paralegal
Dec 1, 2020
Teas Section 71 & 15 Received
Oct 9, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 12, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 8, 2015
Final Decision Transaction Processed By Ib
Dec 23, 2014
Final Disposition Notice Sent To Ib
Dec 23, 2014
Final Disposition Processed
Nov 12, 2014
Final Disposition Notice Created, To Be Sent To Ib
Aug 12, 2014
Registered-Principal Register
May 27, 2014
Official Gazette Publication Confirmation E-Mailed
May 27, 2014
Published For Opposition
May 23, 2014
Notification Processed By Ib
May 7, 2014
Notification Of Possible Opposition Sent To Ib
May 7, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 7, 2014
Notification Of Notice Of Publication E-Mailed
Apr 18, 2014
Law Office Publication Review Completed
Apr 18, 2014
Assigned To Lie
Mar 27, 2014
Approved For Pub - Principal Register
Mar 27, 2014
Examiner's Amendment Entered
Mar 27, 2014
Notification Of Examiners Amendment E-Mailed
Mar 27, 2014
Examiners Amendment E-Mailed
Mar 27, 2014
Examiners Amendment -Written
Feb 22, 2014
Notification Of Final Refusal Emailed
Feb 22, 2014
Final Refusal E-Mailed
Feb 22, 2014
Final Refusal Written
Jan 10, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 10, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 11, 2014
Teas/Email Correspondence Entered
Jan 10, 2014
Correspondence Received In Law Office
Jan 10, 2014
Teas Response To Office Action Received
Sep 17, 2013
Refusal Processed By Ib
Aug 28, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Aug 28, 2013
Refusal Processed By Mpu
Aug 27, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Aug 26, 2013
Non-Final Action Written
Aug 9, 2013
Non-Final Action (Ib Refusal) Withdrawn For Review
Aug 9, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Aug 8, 2013
Non-Final Action Written
Aug 6, 2013
Application Filing Receipt Mailed
Aug 5, 2013
Assigned To Examiner
Aug 2, 2013
New Application Office Supplied Data Entered
Aug 1, 2013
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24